We are live on ! Find out more
CIA

Capital Impact Advisors Portfolio holdings

AUM $247M
1-Year Est. Return 31.15%
This Fund
S&P 500
This Quarter Est. Return
+46.47%
1 Year Est. Return
+31.15%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$407M
AUM Growth
+$69.8M
Cap. Flow
-$22.2M
Cap. Flow %
-5.45%
Top 10 Hldgs %
24.1%
Holding
129
New
20
Increased
20
Reduced
20
Closed
27

Top Buys

Rank Stock Value
1
VCYT icon
Veracyte
VCYT
+$8.34M
2
TWST icon
Twist Bioscience
TWST
+$6.32M
3
SGEN
Seagen Inc. Common Stock
SGEN
+$5.16M
4
PACB icon
Pacific Biosciences
PACB
+$5.1M
5
TDOC icon
Teladoc Health
TDOC
+$4.41M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$11.4M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$8.49M
3
LVGO
Livongo Health, Inc. Common Stock
LVGO
+$6.86M
4
CRSP icon
CRISPR Therapeutics
CRSP
+$5.86M
5
ARWR icon
Arrowhead Research
ARWR
+$5.76M

Sector Composition

Rank Sector Weight
1 Healthcare 45.15%
2 Technology 24.29%
3 Communication Services 9.57%
4 Consumer Discretionary 5.1%
5 Financials 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TWST icon
1
Twist Bioscience
TWST
$5.62B
$13.7M 3.37%
97,000
+57,000
+143% +$6.32M
NTLA icon
2
Intellia Therapeutics
NTLA
$1.5B
$12M 2.94%
220,000
+110,000
+100% +$3.99M
NVTA
3
DELISTED
Invitae Corporation
NVTA
$11.5M 2.82%
275,000
+75,000
+38% +$3.58M
EXAS
4
DELISTED
Exact Sciences
EXAS
$9.23M 2.27%
69,702
+5,000
+8% +$605K
ROKU icon
5
Roku
ROKU
$21.1B
$9.17M 2.25%
27,609
+6,000
+28% +$1.57M
EDIT icon
6
Editas Medicine
EDIT
$399M
$9.11M 2.24%
130,000
+105,000
+420% +$4.31M
ZG icon
7
Zillow
ZG
$7.02B
$8.97M 2.2%
66,000
-14,000
-18% -$1.58M
VCYT icon
8
Veracyte
VCYT
$4.52B
$8.81M 2.16%
+180,000
New +$8.34M
PSNL icon
9
Personalis
PSNL
$1.26B
$7.88M 1.94%
215,380
+135,000
+168% +$4.08M
PACB icon
10
Pacific Biosciences
PACB
$422M
$7.78M 1.91%
+300,000
New +$5.1M
XYZ
11
Block Inc
XYZ
$45.9B
$7.73M 1.9%
35,500
+14,000
+65% +$2.73M
PD icon
12
PagerDuty
PD
$700M
$6.88M 1.69%
165,000
– –
TDOC icon
13
Teladoc Health
TDOC
$1.58B
$6.84M 1.68%
34,196
+21,696
+174% +$4.41M
TWLO icon
14
Twilio
TWLO
$29.1B
$6.77M 1.66%
20,000
+5,000
+33% +$1.56M
ARWR icon
15
Arrowhead Research
ARWR
$12.1B
$6.77M 1.66%
88,183
-90,000
-51% -$5.76M
ARCT icon
16
Arcturus Therapeutics
ARCT
$157M
$6.72M 1.65%
155,000
+45,000
+41% +$3.05M
ZS icon
17
Zscaler
ZS
$23B
$6.29M 1.54%
31,500
+9,750
+45% +$1.55M
LOB icon
18
Live Oak Bancshares
LOB
$1.95B
$6.27M 1.54%
132,025
-30,000
-19% -$1.2M
MASI
19
DELISTED
Masimo
MASI
$6.13M 1.51%
22,850
+7,000
+44% +$1.75M
TRUP icon
20
Trupanion
TRUP
$1.05B
$5.87M 1.44%
49,000
+10,000
+26% +$945K
TTD icon
21
Trade Desk
TTD
$8.13B
$5.85M 1.44%
73,000
-10,620
-13% -$802K
NET icon
22
Cloudflare
NET
$93B
$5.81M 1.43%
76,500
-34,500
-31% -$2.26M
NFLX icon
23
Netflix
NFLX
$292B
$5.62M 1.38%
103,860
– –
BILL icon
24
BILL Holdings
BILL
$4.33B
$5.6M 1.37%
41,000
– –
AGNT
25
AGNT Inc
AGNT
$664M
$5.38M 1.32%
170,600
– –
1
2 3 4 5

Similar funds

AI
AXS Investments Port Chester, New York $248M AUM 15.95% 1-Year Est. Return
AB
ANB Bank Denver, Colorado $247M AUM 19.59% 1-Year Est. Return
ACA
American Capital Advisory Ketchum, Idaho $248M AUM 21.64% 1-Year Est. Return
PWS
Peloton Wealth Strategists Indianapolis, Indiana $247M AUM 13.57% 1-Year Est. Return
BFM
Blacksheep Fund Management Co. Dublin, Ireland $247M AUM 8.75% 1-Year Est. Return
IFPG
Intrepid Financial Planning Group Carmel, Indiana $248M AUM 19.02% 1-Year Est. Return
VWM
Vivid Wealth Management West Des Moines, Iowa $247M AUM 30.07% 1-Year Est. Return
AAG
Avalon Advisory Group Wexford, Pennsylvania $248M AUM 11.89% 1-Year Est. Return

Capital Impact Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Capital Impact Advisors held 129 positions worth $407M, up 21% from $337M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Capital Impact Advisors withdrew a net $22.2M in Q4 2020, closing 27 positions and reducing 20 holdings. Its most notable exit was Livongo Health, Inc. Common Stock, an estimated $6.86M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, up from 31% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Capital Impact Advisors opened a new position in Veracyte worth $8.81M.

  • Capital Impact Advisors's largest Q4 2020 buy was Veracyte: 180,000 shares worth $8.81M.
  • Capital Impact Advisors added most to Twist Bioscience in Q4 2020, an estimated $6.32M increase.
  • Capital Impact Advisors's biggest Q4 2020 reduction was Amazon, cutting an estimated $11.4M.
  • Capital Impact Advisors fully exited Livongo Health, Inc. Common Stock in Q4 2020, selling an estimated $6.86M.
  • Capital Impact Advisors's ten largest holdings make up 24% of its $407M portfolio in Q4 2020.
  • Capital Impact Advisors opened 20 new positions and closed 27 in Q4 2020.
  • Capital Impact Advisors's portfolio value rose 21% quarter-over-quarter to $407M.

Based on Capital Impact Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.